UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008730
Receipt number R000010239
Scientific Title Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)
Date of disclosure of the study information 2012/10/01
Last modified on 2019/08/28 15:34:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)

Acronym

AQUALA study

Scientific Title

Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)

Scientific Title:Acronym

AQUALA study

Region

Japan


Condition

Condition

Hip disorders including osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assessment of effectiveness and safety of the Aquala liner in patients who have the Aquala liner as an acetabular component of artificial hip joint

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Wear of the polyethylene liner

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Ceramic femoral head

Interventions/Control_2

Metal femoral head

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who are indicated for a primary THA, and entered this study on the basis of their agreement to participate in the clinical trial. Patients who are indicated for this surgery on both sides can be included.
2) Patients who have an indication for the Aquala liner with a femoral head of 28 mm or 32 mm in diameter.
3) Patients aged 75 or younger at the time of a written prior consent to participate in this clinical study(no gender selective).

Key exclusion criteria

1) Patients who are not indicated for a primary THA

2) Patients with unstable clinical conditions

3) Patients whose weight is over the weight restriction of the femoral components to be used

4) Patients who are difficult to be followed for 5 years after the index surgery

5) Patients who are unable to evaluate their own QOL

6) Patients whose functions of the hip joints are difficult to evaluate due to disorders of other organs such as heart and nervous system

7) Patients who once had an artificial hip joint in the same hip joint

8) Patients who are at high risk of thrombosis or bleeding

9) Patients susceptive to infection

10)Patients receiving the anticancer drug therapy

11)Patients who are evaluated to be unsuitable for the subject of this study by the investigators

Target sample size

760


Research contact person

Name of lead principal investigator

1st name Sakae
Middle name
Last name Tanaka

Organization

Graduate School of Medicine, The University of Tokyo

Division name

Orthopaedic Surgery, Sensory and Motor System Medicine, Surgical Sciences

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Email

tanakas-ort@h.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Yoshio
Middle name
Last name Takatori

Organization

Graduate School of Medicine, The University of Tokyo

Division name

Div. Science for Joint Reconstruction

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Homepage URL


Email

takatori-orth@umin.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

KYOCERA Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Tokyo, Clinical Research Review Board

Address

Tokyo 7-3-1, Hongo, Bunkyo-ku

Tel

03-5841-0818

Email

ehics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

jRCTs032180333

Org. issuing International ID_1

Japan Registry of Clinical Trials

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 07 Month 09 Day

Date of IRB

2012 Year 07 Month 26 Day

Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Reason for discontinuation:Regisetred to another database
Registration database:Japan Registry of Clinical Trials, ID/jRCTs032180333


Management information

Registered date

2012 Year 08 Month 20 Day

Last modified on

2019 Year 08 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010239